News

Recently HarmonyCR has selected the BSI eTMF solution to support our expanding operations. This software is highly scalable and perfectly tailored to support our growing customer base, both in Europe and overseas. Going live is foreseen for spring 2024.

Our Business Development Manager, Jelle De Keukeleire, is attending the World Vaccine Congress. Join him in Barcelona and let’s meet!

Yesterday, almost the entire team came together for an event. Working with such a great group that gets along very well and shares a lot of humor and joy is a real privilege to be thankful for. Here’s to many more successful and fun moments together!

We are excited to announce the expansion of our operations in The Netherlands, further strengthening our commitment to serving clients in that country. With the addition of a first dedicated employee based centrally in The Netherlands, HarmonyCR is now even better placed to offer enhanced local expertise and presence for its valued clients.

Until now, regulatory and monitoring services in Belgium and The Netherlands were covered with our team of Belgian colleagues, while we collaborate with local partners in other countries. However, with the increasing demand for local expertise and the desire to better fulfill the needs of its clients, the decision was made to establish a dedicated presence in The Netherlands.

To spearhead our operations locally, HarmonyCR proudly welcomes Tamara Koudijs as the first employee based in The Netherlands. With almost 10 years of experience in the regulatory and monitoring domain, Tamara brings a wealth of local expertise to the team. This allows us to offer an even stronger level of local support and expertise to clients and investigators.

Our Business Development Manager, Jelle De Keukeleire, is attending Bio-Europe Spring . Join him in Basel March 20-22, 2023 and let’s meet!

Our Business Development Manager, Jelle De Keukeleire, is attending the Nordic Life Science (NLS) Days in Malmö on 28-29 September 22. He is looking forward to meeting you there!

Harmony’s first clinical trial application through the new Clinical Trial Regulation has been completed successfully! In fact, it only took 45 days (from first submission until receiving the positive final single decision) to get a first-in-human vaccine trial in Belgium approved via the online platform CTIS (Clinical Trials Information System). This shows again what a great place Belgium is to conduct phase I clinical trials!

At our 10^th anniversary, we felt it was the right time to redesign our website. We hope you will enjoy navigating around. In case you would like to learn more about HarmonyCR, please don’t hesitate to contact us!